Genomics

Dataset Information

0

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden


ABSTRACT: Profiling of circulating tumor DNA (ctDNA) may offer a non-invasive approach to monitor disease progression. Here, we developed a quantitative method, exploiting local tissue-specific cell-free DNA (cfDNA) degradation patterns, that accurately estimates ctDNA burden independent of genomic aberrations. Nucleosome-dependent cfDNA degradation at promoters and first exon-intron junctions was strongly associated with differential transcriptional activity in tumors and blood. A quantitative model, based on just 6 regulatory regions, could accurately predict ctDNA levels in colorectal cancer patients. Strikingly, a model restricted to blood-specific regulatory regions could predict ctDNA levels across both colorectal and breast cancer patients.

PROVIDER: EGAS00001004657 | EGA |

REPOSITORIES: EGA

altmetric image

Publications


Profiling of circulating tumor DNA (ctDNA) may offer a non-invasive approach to monitor disease progression. Here, we develop a quantitative method, exploiting local tissue-specific cell-free DNA (cfDNA) degradation patterns, that accurately estimates ctDNA burden independent of genomic aberrations. Nucleosome-dependent cfDNA degradation at promoters and first exon-intron junctions is strongly associated with differential transcriptional activity in tumors and blood. A quantitative model, based  ...[more]

Similar Datasets

2023-01-25 | GSE221317 | GEO
2024-09-18 | GSE274189 | GEO
2021-01-12 | GSE164600 | GEO
2020-01-01 | GSE97923 | GEO
| PRJNA528497 | ENA
2020-01-01 | GSE97932 | GEO
2023-01-01 | GSE193208 | GEO
| PRJNA740302 | ENA
2019-07-01 | GSE118690 | GEO
| 63479 | ecrin-mdr-crc